Creating new technologies to improve cancer treatment through gene modification.
Official title: Development of New Technologies at Roswell Park to Further Cancer-Based Research and Treatment Through Genome Modification
Funded at Roswell Park Cancer Institute Corp · NIH-10931670 · Data updated 2026-11-12
This study is exploring new ways to change genes to improve cancer treatments, and it's for anyone affected by cancer who hopes for better therapies in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project start | September 19, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $324,868 |
| NIH project number | 5R50CA283761-02 |
| Project ID | NIH-10931670 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research are individuals diagnosed with cancer who may be eligible for novel gene-targeted therapies.
✕Less likely to help
Patients with non-cancerous conditions or those who do not meet the criteria for gene-targeted therapies may not receive benefits from this research.
What this research studies
This research focuses on advancing cancer treatment by developing new technologies for genome modification. Led by Dr. Aimee Stablewski at Roswell Park Comprehensive Cancer Center, the project aims to enhance the capabilities of gene targeting and transgenic resources. By collaborating with various cancer researchers, the team will apply innovative genome editing techniques to better understand and treat different types of cancer. Patients may benefit from the insights gained through these advanced methodologies in future therapies.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments tailored to individual genetic profiles.
How similar studies have gone: Previous research in genome modification for cancer treatment has shown promising results, indicating that this approach has the potential for significant advancements.
Where this research is happening
-
Roswell Park Cancer Institute Corp
Buffalo, United States Active
Researchers
- Principal investigator: Stablewski, Aimee B — Roswell Park Cancer Institute Corp
- Study coordinator: Stablewski, Aimee B
Related research
Other NIH-funded projects on the same topics.
-
A network for sharing data and resources in immuno-oncology.
This study is all about bringing together experts to find better ways to treat cancer by understanding why some treatments don’t work and discovering new targets for the immune system, which could lead to more personalized and effective therapies for adults.
-
A network for sharing data and resources in immuno-oncology
This study is all about finding better ways to treat cancer using the body's immune system by working together with different experts to share information, which could lead to new treatments and help patients like you have more effective options.
-
Targeting retrotransposons to help kids with hard-to-treat cancers like neuroblastoma
Aims to repurpose safe antiviral drugs to block retrotransposons in children with relapsed or refractory neuroblastoma to improve outcomes.
-
MedSupport: Helping families overcome barriers to kids' chemotherapy medicines
This program offers extra support to parents of children with acute lymphoblastic leukemia to help them give home chemotherapy medicines more reliably.
-
Innate immune cells and female lung cancer risk
A study exploring how certain immune cells in the lungs may contribute to lung cancer in young women who don’t smoke.
-
Effect of ONP filler materials on how fast nicotine is delivered
This grant tests how different filler materials in oral nicotine pouches affect how quickly nicotine is released and absorbed in the mouth.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.